文献速递鼻科

SPARC蛋白作为慢性鼻窦炎血清生物标志物的评估

An Evaluation of SPARC Protein as a Serum Biomarker of Chronic Rhinosinusitis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-10-02

提示SPARC可能是反映疾病活动的血清标志物,但与上皮间质转化及结局的关系并非线性。

要点

  • SPARC可在慢性鼻窦炎患者血清中稳定检测。

核心结论

  • SPARC可能是反映慢性鼻窦炎疾病活动的血清生物标志物,术后随疾病负担减轻而下降,但不能预测术后演变。

主要发现

  • 所有受试者血清中均可检测到并测量SPARC。

关键数值与推荐

  • 术后结局根据症状学和内镜检查分为「缓解」或「不利」。

临床怎么用

  • SPARC可作为监测慢性鼻窦炎疾病活动的候选血清标志物,但不宜用于预测内镜鼻窦手术后的病情演变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Precision medicine initiatives for chronic rhinosinusitis (CRS) management suggest tailoring treatment to the patient's individual disease profile; however, serum biomarkers for evaluation of disease activity or predicting response to therapy are lacking in CRS. Epithelial-to-mesenchymal transition (EMT) has been described as a component of barrier dysfunction in CRS. SPARC (secreted protein acidic and rich in cysteine) is a marker of EMT that has previously been identified in sinus epithelium by gene expression profiling. We wished to determine if SPARC could represent a serum biomarker for CRS by verifying (1) if SPARC could be detected in serum, (2) whether levels were sensitive to disease burden reduction following surgery, and (3) if it could predict response to therapy. STUDY DESIGN: Prospective. SETTING: Tertiary care center. SUBJECTS: Patients with CRS undergoing endoscopic sinus surgery (ESS). METHODS: Twenty-six patients undergoing ESS for CRS were prospectively recruited. Serum was collected at the time of surgery and 4 months following ESS and SPARC level measured using enzyme-linked immunosorbent assay. Postoperative outcome was characterized as "remission" or "unfavorable" based on symptomatology and endoscopy. RESULTS: SPARC could be detected and measured in serum in all subjects. Following ESS, SPARC levels decreased by 33% ( P = .005) but did not predict evolution at 4 months postsurgery ( P = .94). CONCLUSION: SPARC may be an interesting serum biomarker of disease activity in CRS, as it can be reliably measured and decreases following successful reduction of disease burden after surgery. However, it does not predict post-ESS evolution, suggesting that the link between EMT and outcome is not linear.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Asmar MH, Gaudreau A, Maniakas A, et al. An Evaluation of SPARC Protein as a Serum Biomarker of Chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2018. PMID: 30274534. doi:10.1177/0194599818801888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。